A carregar...
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
Multiple myeloma (MM) is a heterogeneous disease with certain genetic features [eg, t(4;14), del17p] associated with worse outcome. The introduction of thalidomide, lenalidomide, and bortezomib has dramatically improved the outlook for patients with MM, but their relative benefit (or harm) for diffe...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3567336/ https://ncbi.nlm.nih.gov/pubmed/23165477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-05-432203 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|